STOCK TITAN

Pediatrix Medical Group (MD) Stock News, Jul-Nov 2021

MD NYSE

Pediatrix Medical Group, Inc. provides physician services for women, babies and children across hospital settings and office-based practices. Its recurring updates center on obstetrics, maternal-fetal medicine, neonatology, neonatal intensive care unit activity and other pediatric subspecialties, with revenue concentrated in neonatology and pediatric subspecialty care.

Company news also covers quarterly operating results, same-unit revenue trends, reimbursement and payor-mix factors, patient acuity, hospital contract administrative fees, practice acquisitions and dispositions, service expansions, clinical quality initiatives and neonatology education through NEO: The Conference for Neonatology.

Rhea-AI Summary

Mednax, Inc. (NYSE: MD) will present at Credit Suisse’s 30th Annual Healthcare Conference on November 10, 2021, at 1:50 p.m. EST, via live audio webcasts. The company is a national medical group with over 2,300 physicians across 39 states and Puerto Rico, focusing on high-quality, cost-effective healthcare services in pediatrics and obstetrics. Established in 1979, Mednax utilizes evidence-based tools and telehealth programs to improve patient outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags
conferences
-
News
Rhea-AI Summary

Mednax, Inc. (NYSE: MD) reported Q3 2021 earnings of $0.37 per share and adjusted EPS of $0.46, with net revenue reaching $493 million, up from $461 million YoY. Income from continuing operations was $32 million, and adjusted EBITDA was $73 million. Key growth areas included a 5.9% increase in same-unit revenue, primarily driven by a 6.5% rise in patient volume. Mednax's investment in Brave Care aims to enhance pediatric services. Cash reserves stood at $358 million, reflecting a decline from $1.12 billion at the start of the year due to debt redemption efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
-
Rhea-AI Summary

Mednax, Inc. (NYSE: MD) will hold an investor conference call on October 28, 2021, at 9:00 a.m. ET, to discuss quarterly operational results for the quarter and nine months ended September 30, 2021. A detailed press release will be available on the same morning before market open. The call will be accessible via Mednax’s website. Mednax focuses on delivering high-quality medical services through over 2,300 physicians across 39 states and Puerto Rico.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
conferences
Rhea-AI Summary

Mednax, Inc. (NYSE: MD) endorses the CDC's COVID-19 vaccination recommendations, emphasizing the importance of safeguarding at-risk populations, particularly pregnant women and children. With over 400 million doses administered in the U.S., the firm highlights that unvaccinated individuals account for approximately 90% of COVID-19 deaths. This position aligns with other prominent medical associations dedicated to maternal and pediatric care. Mednax's commitment to improving patient outcomes is reinforced through its extensive network of over 2,300 healthcare professionals across 39 states and Puerto Rico.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.30%
Tags
covid-19
-
Rhea-AI Summary

Brave Care, a pediatric healthcare platform, raised $25M in a funding round led by Mednax, Inc. (NYSE: MD). The new investment aims to expand Brave Care's pediatric clinics across the U.S., enhancing access to affordable child healthcare. Currently operating clinics in Portland, OR and Fayetteville, NC, the company plans to open over 100 new facilities. Brave Care seeks to provide quality urgent care, alleviating the burden on emergency rooms for parents of sick children. The investment could significantly enhance patient care and operational capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.40%
Tags
none
-
Rhea-AI Summary

Mednax (NYSE: MD) has announced a $20 million investment in Brave Care, aiming to develop innovative pediatric primary and urgent care clinics across the United States. This partnership will leverage Brave Care's advanced technology and Mednax's clinical expertise, enhancing pediatric care delivery. The investment grants Mednax a minority stake in Brave Care, with plans to open over 100 clinics and rebrand existing facilities under the Pediatrix name. The collaboration signifies a commitment to improving healthcare accessibility for children nationwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.40%
Tags
none
Rhea-AI Summary

Mednax, Inc. (NYSE: MD), a leader in specialized maternal care, reports a record high of pregnant patients critically ill with COVID-19, primarily unvaccinated, as the Delta variant surges. The company emphasizes the importance of vaccination, citing severe complications for high-risk patients. Obstetrix, with nearly 550 clinicians, provides extensive maternal services nationwide, aiming to improve outcomes for critically ill pregnant women. Clinical research continues to monitor COVID-19 effects on pregnant women, with a strong endorsement for vaccination to prevent severe illness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.71%
Tags
covid-19
-
Rhea-AI Summary

Mednax, Inc. (NYSE: MD) announced it will present at Morgan Stanley's 19th Annual Global Healthcare Conference on September 15, 2021, at 12:30 p.m. ET. The presentation will be accessible via live audio webcasts. Mednax is a national medical group with over 2,300 physicians across 39 states and Puerto Rico, focusing on enhancing patient outcomes through evidence-based care and telehealth programs. Founded in 1979, Mednax is committed to high-quality, cost-effective healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.70%
Tags
conferences
-
News
Rhea-AI Summary

Mednax, Inc. (NYSE: MD) reported earnings of $0.36 per share for Q2 2021, with adjusted EPS at $0.41. Net revenue reached $473 million, up from $415.4 million year-over-year. The net income from continuing operations was $31 million, with an adjusted EBITDA of $66 million. The increase in revenue was driven by strong patient volume trends, with same-unit revenue growth of 13.4%. Operating expenses rose, including salaries and benefits totaling $317 million. Cash and equivalents decreased to $338.2 million. Mednax will hold an investor call to discuss results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.26%
Tags
Rhea-AI Summary

Mednax, Inc. (NYSE: MD) will hold an investor conference call on August 6, 2021, at 9:00 a.m. ET to discuss its operational results for the quarter and six months ending June 30, 2021. A detailed press release will be provided that morning. The call will be accessible via Mednax's website. Established in 1979, Mednax comprises over 2,300 physicians across 39 states and Puerto Rico, focusing on enhancing patient care through evidence-based methods and telehealth. Forward-looking statements in the PR highlight potential risks and uncertainties affecting future performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
conferences

FAQ

What is the current stock price of Pediatrix Medical Group (MD)?

Pediatrix Medical Group (MD) last closed at $30.84.

What is the market cap of Pediatrix Medical Group (MD)?

The market cap of Pediatrix Medical Group (MD) is approximately $2.4B.